Abstract
Objective
To determine whether out-of-hospital healthcare and adverse outcomes are better in stroke patients admitted to a neurology ward compared with those admitted to general wards.
Methods
Beneficiaries of the National Health Service from the Italian Lombardy Region who were discharged alive after hospital admission during the year 2009 for ischemic stroke (9776 patients) or intracerebral or subarachnoid hemorrhage (1102 patients) entered into the cohort and were followed until 2012. Exposure of interest was the ward type where inpatients were admitted (neuro vs. general wards). Outcomes were out-of-hospital healthcare (i.e., drug prescriptions, diagnostic procedures, and laboratory clinical evaluations) and adverse clinical outcomes (i.e., all-cause death and hospital readmission). Exposure-outcome associations were investigated. High-dimensional propensity score methodology was used for taking into account confounders. Mediation analysis was used to verify whether the association between ward type and clinical outcomes is mediated by out-of-hospital adherence to healthcare.
Results
Better adherence to out-of-hospital healthcare received from patients discharged from neuro, rather than general, wards was observed being the proportions of adherent patients 42.4% and 39.5%, respectively. Compared with general wards, discharge from neuro was associated with reduced 3-year emergency admissions (from 50.1 to 47.5% among ischemic stroke patients) and reduced 3-year mortality (from 37.5 to 27.0% among hemorrhagic stroke patients). From 10 to 15% of outcome risk, reductions were mediated by better adherence to out-of-hospital healthcare.
Conclusions
For patients with acute ischemic and hemorrhagic stroke, admission to neuro vs. general wards is associated with better out-of-hospital healthcare and long-term adverse outcomes.
Similar content being viewed by others
References
Feigin VL, Norrving B, Mensah GA (2017) Global burden of stroke. Circ Res 120:439–448
Feigin VL, Lawes CMM, Bennett DA, Barker-Collo SL, Parag V (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8:355–369
Koton S, Schneider AL, Rosamond WD et al (2014) Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA 312:259–268
Schmidt M, Jacobsen JB, Johnsen SP, Botker HE, Sorensen HT (2014) Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity. Neurology 82:340–350
Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, Kissela BM, Kittner SJ, Lichtman JH, Lisabeth LD, Schwamm LH, Smith EE, Towfighi A, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Quality of Care and Outcomes Research, Council on Functional Genomics and Translational Biology (2014) Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 45:315–353
GBD 2015 Mortality and Causes of Death Collaborators (2016) Global, regional and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459–1544
Diringer MN, Edwards DF (2001) Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med 29:635–640
Agostoni E, Carolei A, Micieli G, Provinciali L, Toni D, Vidale S (2018) The organisation of the acute ischemic stroke management: key notes of the Italian Neurological Society and of the Italian Stroke Organization. Neurol Sci 39:415–422
Corrao G, Rea F, Merlino L, Mazzola P, Annoni F, Annoni G (2017) Management, prognosis and predictors of unfavourable outcomes in patients newly hospitalized for transient ischemic attack: a real-world investigation from Italy. BMC Neurol 17:12
Corrao G, Rea F, Di Martino M et al (2017) Developing and validating a novel multisource comorbidity score from administrative data: a large population-based cohort study from Italy. BMJ Open 7:e019503
Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA (2009) High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 20:512–522
Rassen JA, Glynn RJ, Brookhart MA, Schneeweiss S (2011) Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol 173:1404–1413
Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94:496–509
Vanderweele TJ, Vansteelandt S (2010) Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol 172:1339–1348
Ayis SA, Coker B, Bhalla A, Wellwood I, Rudd AG, di Carlo A, Bejot Y, Ryglewicz D, Rastenyte D, Langhorne P, Dennis MS, McKevitt C, Wolfe CDA (2013) Variations in acute stroke care and the impact of organised care on survival from a European perspective: the European Registers of Stroke (EROS) investigators. J Neurol Neurosurg Psychiatry 84:604–612
Malmivaara A, A. Meretoja A, M. Peltola M.,M. Peltola, D. Numerato, R. Heijink, P. Engelfriet, S.H. Wild, É. Belicza, D. Bereczki, E. Medin, F. Goude, G. Boncoraglio, T. Tatlisumak, T. Seppälä, U. Häkkinen (2015) Comparing ischaemic stroke in six European countries. The EuroHOPE register study. Eur J Neurol 22:284–291
Santalucia P, Baviera M, Cortesi L, Tettamanti M, Marzona I, Nobili A, Riva E, Fortino I, Bortolotti A, Merlino L, Roncaglioni MC (2015) Epidemiologic trends in hospitalized ischemic stroke from 2002 to 2010: results from a large Italian population-based study. J Stroke Cerebrovasc Dis 24:1917–1923
Cesaroni G, Agabiti N, Forastiere F, Perucci CA (2009) Socioeconomic differences in stroke incidence and prognosis under a universal healthcare system. Stroke 40:2812–2819
Stuart M, Papini D, Benvenuti F, Nerattini M, Roccato E, Macellari V, Stanhope S, Macko R, Weinrich M (2010) Methodological issues in monitoring health services and outcomes for stroke survivors: a case study. Dis Health J 3:271–281
Finocchi C, Balestrino M, Malfatto L, Mancardi G, Serrati C, Gandolfo C (2018) National Institutes of Health Stroke Scale in patients with primary intracerebral hemorrhage. Neurol Sci 39:1751–1755
Candelise L, Gattinoni M, Bersano A, Micieli G, Sterzi R, Morabito A, PROSIT Study Group (2007) Stroke-unit care for acute stroke patients: an observational follow-up study. Lancet 369:299–305
Sun Y, Paulus D, Eyssen M, Maervoet J, Saka O (2013) A systematic review and meta-analysis of acute stroke unit care: what’s beyond the statistical significance? BMC Med Res Methodol 13:132
Nardetto L, Giometto B, Moretto G, Mantoan D, Saia M (2017) Hub-and-spoke stroke network in the Veneto region: a retrospective study investigating the effectiveness of the stroke pathway and trends over time. Neurol Sci 38:2117–2121
Hankey GJ (2014) Secondary stroke prevention. Lancet Neurol 13:178–194
Chan DK, O’Rourke F, Shen Q et al (2011) Meta-analysis of the cardiovascular benefits of intensive lipid lowering with statins. Acta Neurol Scand 124:188–195
Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA, American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease (2014) Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45:2160–2236
Coutts SB, Wein TH, Lindsay MP, Buck B, Cote R, Ellis P, Foley N, Hill MD, Jaspers S, Jin AY, Kwiatkowski B, MacPhail C, McNamara-Morse D, McMurtry MS, Mysak T, Pipe A, Silver K, Smith EE, Gubitz G (2015) Canadian stroke best practice recommendations: secondary prevention of stroke guidelines, update 2014. Int J Stroke 10:282–291
Enthoven AC (2009) Integrated delivery systems: the cure for fragmentation. Am J Manag Care 15:S284–S290
Stange KC (2009) The problem of fragmentation and the need for integrative solutions. Ann Fam Med 7:100–103
Farrell TW, Tomoaia-Cotisel A, Scammon DL, Brunisholz K, Kim J, Day J, Gren LH, Wallace S, Gunning K, Tabler J, Magill MK (2015) Impact of an integrated transition management program in primary care on hospital readmissions. J Healthc Qual 37:81–92
Specogna AV, Turin TC, Patten SB, Hill MD (2017) Hospital treatment costs and length of stay associated with hypertension and multimorbidity after hemorrhagic stroke. BMC Neurol 17:158
Norrving B, Kissela B (2013) The global burden of stroke and need for a continuum of care. Neurology 80:S5–S12
Corrao G, Mancia G (2015) Generating evidence from computerized healthcare utilization databases. Hypertension 65:490–498
Baldereschi M, Balzi D, Di Fabrizio V et al (2018) Administrative data underestimate acute ischemic stroke events and thrombolysis treatments: data from a multicentre validation survey in Italy. PLoS One 13:e0193776
Patorno E, Glynn RJ, Hernández-Díaz S, Liu J, Schneeweiss S (2014) Studies with many covariates and few outcomes: selecting covariates and implementing propensity-score-based confounding adjustments. Epidemiology 25:268–278
Acknowledgments
The authors wish to thank the past (Leandro Provinciali) and the present President (Gianluigi Mancardi) of Italian Society of Neurology (SIN) together with SIN Board of Directors who supported with their encouragement the realization of this research.
Funding
This work has been realized by means of an unconditioned grant from Italian Society of Neurology (SIN). SIN had no role in the design of the study, the collection, analysis, and interpretation of the data, as well as the writing of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Giovanni Corrao received research support from the European Community (EC), the Italian Agency of Drug (AIFA), and the Italian Ministry of Education, University and Research (MIUR). He took part in a variety of projects that were funded by pharmaceutical companies (i.e., Novartis, GSK, Roche, AMGEN, and BMS). He also received honoraria as member of Advisory Board from Roche.
Other authors declare that they have no conflict of interest to disclose.
Research involving human participants and/or animals/informed consent
For this type of study, formal consent is not required.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 20 kb)
Rights and permissions
About this article
Cite this article
Rea, F., Micieli, G., Musicco, M. et al. Adherence to recommendations and clinical outcomes of patients hospitalized for stroke: the role of the admission ward—a real-life investigation from Italy. Neurol Sci 40, 1433–1442 (2019). https://doi.org/10.1007/s10072-019-03867-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-019-03867-7